Fellowship · New Haven, CT
Sponsored by Yale-New Haven Hospital
Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders.
JAMA dermatology · 2024 · 54 citations · Richard Antaya
Nonsyndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
The British journal of dermatology · 2025 · 53 citations · Keith Choate
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Journal of the American Academy of Dermatology · 2024 · 71 citations · Jean Bolognia
Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
The British journal of dermatology · 2025 · 37 citations · Keith Choate
Palmoplantar epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
The British journal of dermatology · 2025 · 32 citations · Keith Choate
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results.
Journal of the American Academy of Dermatology · 2021 · 157 citations ·
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.
JAMA dermatology · 2024 · 31 citations · Brittany Craiglow, Seth Orlow
When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials.
The British journal of dermatology · 2023 · 50 citations · Brittany Craiglow